The stock is currently trading 21.12% above its 20-day simple moving average (SMA) and 12.9% above its 100-day SMA, ...
SpyGlass Pharma (SGP) has filed for a proposed Nasdaq IPO.
Analysis of 20 years of data highlights differences in reimbursement trends across ophthalmology subspecialties and practice ...
Just a few years ago, the lion’s share of investment in new ophthalmic drugs was for topical antibiotics.The target market ...
Mu Medical, a medical technology company aiming to support “the full life cycle of ocular care,” is set to be formed out of a ...
A trial shows minimally invasive nasal trabeculostomy can offer sustained IOP reduction and medication-free success in glaucoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback